Statistics for Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer
Total visits
views | |
---|---|
Targeting CXCL16 and STAT1 augments immune checkpoint blockade therapy in triple-negative breast cancer | 2 |
Total visits per month
views | |
---|---|
October 2024 | 0 |
November 2024 | 0 |
December 2024 | 0 |
January 2025 | 0 |
February 2025 | 0 |
March 2025 | 0 |
April 2025 | 0 |
File Visits
views | |
---|---|
java.util.UUID:eb3f756f-571a-4470-9798-3cfbc7172fc5 | 14 |
java.util.UUID:f19b0623-a379-4444-a18e-c9fa945db855 | 14 |
41467_2023_Article_37727.pdf | 10 |
java.util.UUID:a975a1e3-dbed-4d7a-abce-8dce47e33bdb | 5 |
Top country views
views | |
---|---|
United States | 2 |
Top city views
views | |
---|---|
Greenwood | 2 |